Riabov, V., Xu, Q., Schmitt, N., Streuer, A., Ge, G., Bolanos, L., Wunderlich, M., Jann, J.-C., Wein, A., Altrock, E., Demmerle, M., Mukherjee, S., Ali, A. M., Rapp, F., Nowak, V., Weimer, N., Obländer, J., Palme, I., Göl, M., Jawhar, A., Darwich, A., Wuchter, P., Weiss, C., Raza, A., Foulks, J. M., Starczynowski, D. T., Yang, F.-C., Metzgeroth, G., Steiner, L., Jawhar, M., Hofmann, W.-K. and Nowak, D. (2024) “<i>ASXL1</i&gt; mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms”, Haematologica. Pavia, Italy, 109(5), pp. 1426-1438. doi: 10.3324/haematol.2023.282921.